Case ID: f-appx_104/html/0742-01.html
Source: Caselaw Access Project
Author: {"author": "", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

NAPRO BIOTHERAPEUTICS, INC. (now known as Tapestry Pharmaceuticals, Inc.) and Maybe Pharma (USA) Inc. (now known as Faulding Pharmaceutical Co.), Plaintiffs-Appellees, v. MYLAN LABORATORIES INC., Mylan Pharmaceuticals, Inc. and UDL Laboratories, Inc., Defendants-Appellants.
    No. 04-1170.
    United States Court of Appeals, Federal Circuit.
    Aug. 4, 2004.
    George C. Lombardi, Principal Attorney, James F. Hurst, Alice L. Riechers, David J. Doyle, of Counsel, Winston & Strawn, Kristen G. Cowan, of Counsel, Chicago, IL, Robert M. Linn, of Counsel, Cohen & Grigsby, Pittsburgh, PA, for Plaintiffs-Appellees.
    E. Anthony Figg, Principal Attorney, Glenn E. Karta, Martin M. Zoltick, Sharon L. Davis, of Counsel, Rothwell, Figg, Washington, DC, for Defendants-Appellants.
   ON MOTION

ORDER

Upon consideration of the parties’ joint motion to voluntarily dismiss this appeal, due to settlement,

IT IS ORDERED THAT:

(1) The motion is granted.

(2) Each side shall bear its own costs.